Valuation: Augmedix, Inc.

Market Cap 116M 101M 95.13M 86.21M 162M 11.13B 163M 1.14B 437M 5.65B 436M 427M 18.02B P/E 2022
-2.39x
P/E 2023 -13.4x
Enterprise Value 95.78M 83.02M 78.45M 71.09M 133M 9.18B 134M 936M 360M 4.66B 360M 352M 14.86B EV / Sales 2022
1.75x
EV / Sales 2023 5.88x
Free-Float
99.74%
Yield 2022 *
-
Yield 2023 -
3 years 0.73
Extreme 0.73
6.25
5 years 0.73
Extreme 0.73
6.25
10 years 0.73
Extreme 0.73
10
Manager TitleAgeSince
Chief Executive Officer - 02/10/2024
Director of Finance/CFO - 02/10/2024
Chief Operating Officer - 02/10/2024
Director TitleAgeSince
Director/Board Member 63 10/04/2023
Director/Board Member - 02/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
10/2/24 A Issuer sale

Chief Operating Officer

839,548 1.6985%
10/2/24 A Issuer sale

Director

149,581 0.3026%
10/2/24 A Issuer sale

Chief Financial Officer

754,058 1.5256%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-55.58% 116M
-0.93%-0.76%-1.69%+52.05% 80.36B
+0.58%-0.90%-1.22%+8.14% 16.86B
-0.54%+2.70%+3.50%+15.99% 14.31B
+0.17%+0.26%+25.59%+39.94% 12.11B
-0.19%-4.22%+8.82%+78.90% 7.57B
+1.53%-0.21%+37.61%+145.75% 6.55B
-1.56%-3.91%-15.66%-3.16% 6.12B
-0.44%-0.93%-16.75%+23.86% 5.53B
+0.77%-1.06%+18.87%-0.23% 5.17B
Average -0.06%-0.99%+5.91%+30.57% 15.47B
Weighted average by Cap. -0.45%-0.37%+2.75%+43.24%

Financials

2022 2023
Net sales 30.93M 26.81M 25.33M 22.96M 43.06M 2.96B 43.4M 302M 116M 1.5B 116M 114M 4.8B 44.86M 38.88M 36.74M 33.29M 62.45M 4.3B 62.94M 438M 169M 2.18B 168M 165M 6.96B
Net income -24.45M -21.19M -20.02M -18.15M -34.04M -2.34B -34.3M -239M -91.95M -1.19B -91.83M -89.79M -3.79B -19.17M -16.62M -15.7M -14.23M -26.69M -1.84B -26.9M -187M -72.1M -932M -72.01M -70.41M -2.97B
Net Debt -4.28M -3.71M -3.5M -3.17M -5.95M -410M -6M -41.8M -16.08M -208M -16.06M -15.71M -664M -20.37M -17.66M -16.68M -15.12M -28.36M -1.95B -28.58M -199M -76.61M -990M -76.51M -74.81M -3.16B
Logo Augmedix, Inc.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Employees
1,430
  1. Stock Market
  2. Stocks
  3. AUGX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!